Abstract:Pt(IV) anticancer compounds have been developed for several decades to overcome the drawbacks of their Pt(II) congeners, and the reduction of Pt(IV) to Pt(II) has been commonly regarded as a necessary step in the activation of Pt(IV) compounds prior to targeting DNA. However, blockage of glutathione (GSH) biosynthesis resulted in a slight effect on the cytotoxicity of oxoplatin in yeast Saccharomyces cerevisiae strains, urging us to reconsider the mechanism of actions for the "inert" Pt(IV) complexes. Using X-ray absorption near-edge spectroscopy (XANES), our data demonstrated that Pt(IV) complex oxoplatin could bind to DNA in a tetravalent state. Both alkaline denaturing agarose electrophoresis and thermal denaturation-renaturation assay revealed that oxoplatin could rapidly produce stable interstrand crosslinks (ICLs), which can further translate into a fast cell-killing process in cancer cells. Using quantitative real-time PCR and immunofluorescence analysis, we also proved that Pt(IV) complex oxoplatin could induce a quick intracellular response of the FA/BRCA pathway in cancer cells that involves the DNA interstrand crosslinking repair system, and this quick response to ICLs was independent with the intracellular GSH levels. Cell cycle analysis showed that short incubation with oxoplatin can induce a strong S phase arrest in HeLa cells, indicating that the rapid interstrand crosslinks produced by oxoplatin might stall the replication fork, result in the double-strand breaks, and eventually induce cell death. Our results implied that, besides the reduction mechanism to release the Pt(II) congeners, direct and rapid interstrand cross-linking with DNA by Pt(IV) compounds might be a unique mechanism for Pt(IV) compounds, which may provide new insight for the development of next-generation platinum-based drugs.

Study on the Interactions Between Anti-Cancer Drug Oxaliplatin and DNA

Study on the interactions between anti-cancer drug oxaliplatin and DNA by atomic force microscopy

Structural study on the interactions of oxaliplatin and linear DNA.

Molecular Mechanisms of Chemoresistance and Cytotoxicity Associated with Platinum Drugs

Structural Basis for the Structure-Activity Behaviour of Oxaliplatin and its Enantiomeric Analogues: A Molecular Dynamics Study of Platinum-DNA Intrastrand Crosslink Adducts

Toward a better understanding of the oxaliplatin mode of action upon the steric hindrance of 1,2-diaminocyclohexane and its analogue.

Structural characterization and DNA interactions of new cytotoxic transplatin analogues containing one planar and one nonplanar heterocyclic amine ligand

Superior cytotoxicity and DNA cross-link induction by oxaliplatin versus cisplatin at lower cellular uptake in colorectal cancer cell lines

Interaction Between DNA and Oxaliplatin in Aqueous Solution Studied Using THz-TDS

Research Advances in Molecular Mechanism of Oxaliplatin-cetuximab Combination Therapy

DNA or Not DNA —that is the Question Determining the Design of Platinum Anticancer Drugs

Structural changes of linear DNA molecules induced by cisplatin.

Identification and Characterization of DNA-Oxaliplatin Adducts through α-hemolysin Nanopores

Oxaliplatin derived monofunctional triazole-containing platinum(II) complex counteracts oxaliplatin-induced drug resistance in colorectal cancer

Novel Oxaliplatin Derivatives with 1-(Substituted Benzyl)azetidine-3,3-dicarboxylate Anions. Synthesis, Cytotoxicity, and Interaction with DNA.

Proteomic Analysis of Cisplatin- and Oxaliplatin-Induced Phosphorylation in Proteins Bound to Pt-DNA Adducts.

Rapid DNA interstrand cross-linking of Pt(IV) compound

The interactions of cisplatin and DNA studied by atomic force microscopy.

Effects of Ph on Oxaliplatin-Induced Condensation of Single DNA Molecules

Antitumor Activities and Interaction with DNA of Oxaliplatin-Type Platinum Complexes with Linear or Branched Alkoxyacetates As Leaving Groups.

Theoretical Investigation of Interaction Between Unclassical Trinuclear Antitumor Platinum Complex and DNA Duplex